First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1076
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015) ; volume:176 ; number:3 ; day:20 ; month:1 ; year:2017 ; pages:413-422 ; date:3.2017
Zeitschrift für Kinderheilkunde ; 176, Heft 3 (20.1.2017), 413-422, 3.2017
- Keyword
-
Pädiatrie
Kinderkrankheit
- Contributor
-
Wang, Daniel Y.
Li, Abby
Paes, Bosco
Mitchell, Ian
Lanctôt, Krista L.
SpringerLink (Online service)
- DOI
-
10.1007/s00431-017-2849-4
- URN
-
urn:nbn:de:1111-201703158072
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Daniel Y.
- Li, Abby
- Paes, Bosco
- Mitchell, Ian
- Lanctôt, Krista L.
- SpringerLink (Online service)
Other Objects (12)
Palivizumab for prophylaxis of respiratory syncytial virus infections in preterm neonates
Bioenergetics of murine lungs infected with respiratory syncytial virus
Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a systematic review
Severe Respiratory Syncytial Virus Infection
Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection
A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom /
Das Respiratory syncytial Virus : Eine Durchseuchungsstudie
Das Respiratory-Syncytial-<RS>-Virus-Antigen
An update on respiratory syncytial virus
Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands
Cotton rat lung transcriptome reveals host immune response to Respiratory Syncytial Virus infection
Palivizumab for prophylaxis of respiratory syncytial virus infections in preterm neonates
Bioenergetics of murine lungs infected with respiratory syncytial virus
Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a systematic review
Severe Respiratory Syncytial Virus Infection
Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection
A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom /
Das Respiratory syncytial Virus : Eine Durchseuchungsstudie
Das Respiratory-Syncytial-<RS>-Virus-Antigen
An update on respiratory syncytial virus
Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands
Cotton rat lung transcriptome reveals host immune response to Respiratory Syncytial Virus infection
Palivizumab for prophylaxis of respiratory syncytial virus infections in preterm neonates
Bioenergetics of murine lungs infected with respiratory syncytial virus
Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a systematic review
Severe Respiratory Syncytial Virus Infection
Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection
A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom /
Das Respiratory syncytial Virus : Eine Durchseuchungsstudie
Das Respiratory-Syncytial-<RS>-Virus-Antigen
An update on respiratory syncytial virus
Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands